European benchmarks were hit in early trading by a fall across the banking sector Thursday as investors reacted to the latest Fed meeting minutes that suggest a move to lighten its mammoth balance sheet could be just around the corner.

Minutes from the Federal Open Market Committee meeting showed a growing consensus among rate setters that it is time for the U.S. central bank to begin dumping some of the Treasuries and mortgage bonds that it picked up during the course of its quantitative easing program.

"Although several participants were prepared to announce a starting date for the program at the current meeting, most preferred to defer that decision until an upcoming meeting while accumulating additional information on the economic outlook and developments potentially affecting financial markets," the minutes read. 

The Fed said earlier this month that its balance sheet has expanded from $896 billion in 2007 to "well over $2 trillion" today. 

The FTSE 100 and CAC 40 indices led the charge lower from London and Paris Thursday, dropping 0.14% and 0.13% respectively, to 7,410 and 5,154. In Frankfurt, the DAX index dropped 0.10% to 12,251 while, over in Southern Europe, the IBEX was down 0.12% in Madrid and the FTSE MIB was up by a fraction in Milan. 

U.S. markets look set to open down on Thursday. Dow Jones Industrial Average futures were down 0.04% and S&P 500 future losing 0.07% as worries mount over President Donald Trump's agenda and markets digested the Fed's concern over weak inflation.

The dollar Index fell 0.1% against a basket of major currencies, extending the 0.4% slide on Wednesday. Meanwhile, the yield on 10-year Treasuries was at 2.23% after sliding five basis points overnight.

In London the top fallers were Standard Life (SLFPF) , Kingfisher (KGFHY) and Hikma Pharmaceuticals (HKMPY) .

Kingfisher, the home improvements retailer, saw its shares slide more than 3% after it weaker sales in France and its U.K. division led the company to miss analyst estimates for its top line in the second quarter. 

Hikma Pharmaceuticals stock fell by around 7% during early trading after it failed to offset market concerns over how soon it can get its generic Advair Diskus product approved by the Food & Drug Administration.

The company also delivered a poor set of half-year numbers, with sales across all of its key segments coming in below expectations for the six months to June 30. 

Over in Paris, the biggest fallers on the CAC 40 index were Societe Generale (SCGLY) and BNP Paribas (BNPQY) , which were down by close to 1% each. In Frankfurt, Deutsche Bank (DB) fell to the bottom of the DAX index after shedding 0.70%, followed closely by sports clothing retailer Adidas (ADDYY) and Commerzbank (CRZBY) . 

More of What's Trending on TheStreet:

More from Markets

Morgan Stanley M&A Prowess to Remain Strong; Google Dealt Another EU Fine--ICYMI

Morgan Stanley M&A Prowess to Remain Strong; Google Dealt Another EU Fine--ICYMI

Trump's Trade War Hurts U.S. Energy Companies, May Help China

Trump's Trade War Hurts U.S. Energy Companies, May Help China

One Chart Will Make You Even More Pumped Up to Buy Tech Stocks

One Chart Will Make You Even More Pumped Up to Buy Tech Stocks

Jim Cramer's Biggest Moments From Delivering Alpha

Jim Cramer's Biggest Moments From Delivering Alpha

'I Don't Think the Market Always Has the Right Idea' Says Bannon

'I Don't Think the Market Always Has the Right Idea' Says Bannon